임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

19건 표시

4상모집 예정· Eosinophilic Asthma
Fasenra: An Asthma Study
협력: 아스트라제네카
상세 →NCT07654842
4상모집 중· Stomatitis
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
리드: 아스트라제네카
상세 →NCT07357597
4상모집 중· Non-small Cell Lung Cancer
Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.
리드: 아스트라제네카
상세 →NCT07279935
4상모집 중· Severe Asthma
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
협력: 아스트라제네카
상세 →NCT06705764
4상모집 중· Acute Coronary Syndromes (ACS)
Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
협력: 아스트라제네카
상세 →NCT07476859
4상모집 중· Systemic Lupus Erythematosus
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
리드: 아스트라제네카
상세 →NCT06594068
4상모집 중· Moderate to Severe COPD
Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease
리드: 아스트라제네카
상세 →NCT06531798
4상모집 중· Chronic Obstructive Pulmonary Disease
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
리드: 아스트라제네카
상세 →NCT07073950
4상모집 중· Healthy Young Adults
Characterizing the Human Airway Immune Response to FluMist Vaccination
협력: 아스트라제네카
상세 →NCT07177417
4상모집 중· Chronic Lymphocytic Leukaemia
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
리드: 아스트라제네카
상세 →NCT06651970
4상모집 중· BREAST CANCER
Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients
리드: 아스트라제네카
상세 →NCT06429761
4상모집 중단 (진행 중)· Chronic Kidney Disease
A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease
리드: 아스트라제네카
상세 →NCT06610526
4상모집 중단 (진행 중)· Asthma
Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care
리드: 아스트라제네카
상세 →NCT06422689
4상초청 등록· Heart Failure
The Fontan Dapagliflozin Pilot Study
협력: 아스트라제네카
상세 →NCT05741658
4상모집 중· Type2diabetes
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
협력: 아스트라제네카
상세 →NCT06054035
4상모집 중단 (진행 중)· Carcinoma, Ovarian Epithelial
First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients
협력: 아스트라제네카
상세 →NCT06121401
4상모집 중단 (진행 중)· Metastatic Castration-resistant Prostate Cancer
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
리드: 아스트라제네카 · 협력: 머크(MSD)
상세 →NCT05457257
4상모집 중· Asthma; Eosinophilic
Predictive Signature of Benralizumab Response
협력: 아스트라제네카
상세 →NCT04565483
4상모집 중단 (진행 중)· Asthma
Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
리드: 아스트라제네카
상세 →NCT03953300

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.